994. Deputy Michael McGrath asked the Minister for Health if the Health Service Executive has been approached by the manufacturer of a medicine called Kuvan or sapropterin, which is used to treat persons with phenylketonuria, PKU, for reimbursement on the condition that the company will cover the initial cost of the drug and only if the patient responds to treatment will the HSE take over the cost; and if he will make a statement on the matter. [31412/15]

Summary

994. Deputy Michael McGrath asked the Minister for Health if the Health Service Executive has been approached by the manufacturer of a medicine called Kuvan or sapropterin, which is used to treat persons with phenylketonuria, PKU, for reimbursement on the condition that the company will cover the initial cost of the drug and only if the patient responds to treatment will the HSE take over the cost; and if he will make a statement on the matter. [31412/15]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 22 September 2015

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.